Acadian Asset Management LLC Moderna, Inc. Transaction History

Acadian Asset Management LLC

$32.2 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$101.21 - $166.61 $767,677 - $1.26 Million	7,585 New	7,585 $900,000
Q4 2023 Feb 13, 2024	BUY	$69.51 - $104.43 $269,768 - $405,292	3,881 Added 537.53%	4,603 $457,000
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $188,192 - $247,142	-1,952 Reduced 73.0%	722 $74,000
Q2 2023 Aug 07, 2023	SELL	$118.5 - $160.53 $202,161 - $273,864	-1,706 Reduced 38.95%	2,674 $324,000
Q1 2023 May 11, 2023	BUY	$135.66 - $197.02 $16,414 - $23,839	121 Added 2.84%	4,380 $672,000
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $981,133 - $1.74 Million	-8,288 Reduced 66.06%	4,259 $764,000
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $715,622 - $1.18 Million	6,061 Added 93.45%	12,547 $1.48 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $715,622 - $1.18 Million	6,061 Added 93.45%	12,547 $1.48 Million
Q2 2022 Aug 09, 2022	BUY	$117.13 - $176.59 $3,045 - $4,591	26 Added 0.4%	6,486 $927,000
Q1 2022 May 12, 2022	SELL	$126.46 - $235.05 $163,259 - $303,449	-1,291 Reduced 16.66%	6,460 $1.11 Million
Q4 2021 Feb 10, 2022	SELL	$225.82 - $368.51 $607,681 - $991,660	-2,691 Reduced 25.77%	7,751 $1.97 Million
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $1.97 Million - $4.3 Million	-8,867 Reduced 45.92%	10,442 $4.02 Million
Q2 2021 Aug 11, 2021	BUY	$129.91 - $234.98 $1.48 Million - $2.68 Million	11,415 Added 144.6%	19,309 $4.54 Million
Q1 2021 May 11, 2021	BUY	$109.18 - $185.98 $379,400 - $646,280	3,475 Added 78.64%	7,894 $1.03 Million
Q3 2020 Nov 09, 2020	BUY	$54.34 - $94.85 $64,827 - $113,156	1,193 Added 36.98%	4,419 $313,000
Q2 2020 Aug 12, 2020	BUY	$29.67 - $80.0 $95,715 - $258,080	3,226 New	3,226 $208,000

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account